The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EARLY CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials.
 
David Lorente
No Relationships to Disclose
 
David Olmos
Consulting or Advisory Role - Janssen; Veridex
Speakers' Bureau - Janssen; Veridex
 
Joaquin Mateo
No Relationships to Disclose
 
Diletta Bianchini
No Relationships to Disclose
 
George Seed
No Relationships to Disclose
 
Penelope Flohr
No Relationships to Disclose
 
Mateus Crespo
No Relationships to Disclose
 
Ines Figueiredo
No Relationships to Disclose
 
Susana Miranda
No Relationships to Disclose
 
Kurt Baeten
Employment - Janssen
 
Tim Pitfield
Employment - Veridex
 
Arturo Molina
Employment - Janssen
 
Thian Kheoh
Employment - Janssen
 
Robert Thomas Mccormack
Employment - Veridex
 
Howard I. Scher
Honoraria - Chugai Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endo Pharmaceuticals; Endocyte; Exelixis; Ferring; Foundation Medicine; Genentech; Janssen; Medivation; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Exelixis (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endocyte; Exelixis; Ferring; Genentech; Janssen; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group
 
Johann Sebastian De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - Arno Therapeutics (Inst); AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)